Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 Era. | Front Med (Lausanne) | 2021 | 34490299 | PubTator, text mining | PubMed |
| Genetic Risk Factors for the Development of COVID-19 Coronavirus Infection. | Russ J Genet | 2021 | 34483599 | PubTator, text mining | PubMed |
| Exposure to a mixture of legacy, alternative, and replacement per- and polyfluoroalkyl substances (PFAS) results in sex-dependent modulation of cholesterol metabolism and liver injury. | Environ Int | 2021 | 34479135 | PubTator, text mining | PubMed |
| Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study. | J Viral Hepat | 2021 | 34467593 | PubTator, text mining | PubMed |
| The Functions of Hepatitis B Virus Encoding Proteins: Viral Persistence and Liver Pathogenesis. | Front Immunol | 2021 | 34456908 | PubTator, text mining | PubMed |
| Tree Shrew as an Emerging Small Animal Model for Human Viral Infection: A Recent Overview. | Viruses | 2021 | 34452505 | PubTator, text mining | PubMed |
| Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters. | Viruses | 2021 | 34452431 | PubTator, text mining | PubMed |
| Cell Culture Models for the Study of Hepatitis D Virus Entry and Infection. | Viruses | 2021 | 34452397 | PubTator, text mining | PubMed |
| Rapid and Robust Continuous Purification of High-Titer Hepatitis B Virus for In Vitro and In Vivo Applications. | Viruses | 2021 | 34452368 | PubTator, text mining | PubMed |
| Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening. | Viruses | 2021 | 34452354 | PubTator, text mining | PubMed |
| Mechanism of Hepatitis B Virus cccDNA Formation. | Viruses | 2021 | 34452329 | PubTator, text mining | PubMed |
| Hepatitis B virus infection modeling using multi-cellular organoids derived from human induced pluripotent stem cells. | World J Gastroenterol | 2021 | 34447226 | PubTator, text mining | PubMed |
| Organic Anion Transporting Polypeptide 1B1 Is a Potential Reporter for Dual MR and Optical Imaging. | Int J Mol Sci | 2021 | 34445497 | PubTator, text mining | PubMed |
| The Accumulation and Molecular Effects of Trimethylamine N-Oxide on Metabolic Tissues: It's Not All Bad. | Nutrients | 2021 | 34445033 | PubTator, text mining | PubMed |
| Omega-3 Polyunsaturated Fatty Acid: A Pharmaco-Nutraceutical Approach to Improve the Responsiveness to Ursodeoxycholic Acid. | Nutrients | 2021 | 34444777 | PubTator, text mining | PubMed |
| Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease. | Cells | 2021 | 34440841 | PubTator, text mining | PubMed |
| Bile Salt and FGF19 Signaling in the Early Phase of Human Liver Regeneration. | Hepatol Commun | 2021 | 34430784 | PubTator, text mining | PubMed |
| Entry of hepatitis B virus: going beyond NTCP to the nucleus. | Curr Opin Virol | 2021 | 34428726 | PubTator, text mining | PubMed |
| Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage Adjustment. | Mol Pharm | 2021 | 34428046 | PubTator, text mining | PubMed |
| Functional hit 1 (FH1)-based rapid and efficient generation of functional hepatocytes from human mesenchymal stem cells: a novel strategy for hepatic differentiation. | Ann Transl Med | 2021 | 34422999 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=56